StartUp Health March 25, 2025
Investments in programmed medicines, AI-powered pathology, digital pharmacies, senior care solutions, and stroke imaging highlight a week of strong health tech funding—from Boston to Mumbai, Oxford to Tel Aviv.
Ampersand Biosciences, a Boston, MA-based multi-product platform company developing smart medicines, raised $65M from Ampersand’s founder, Flagship Pioneering, Eli Lilly & Company, and other investors. source>
Navina, a New York, NY-based AI-powered clinical intelligence platform, raised $55M led by Growth Equity at Goldman Sachs Alternatives, with participation from Vertex Ventures Israel, Grove Ventures, and ALIVE. source>
Proscia, a Philadelphia, PA-based software company...
Today's Sponsors
Today's Sponsor